Article

Daily Medication Pearl: Ondansetron Hydrochloride (Zofran)

Zofran aids in the prevention of nausea and vomiting.

Medication Pearl of the Day: Ondansetron Hydrochloride (Zofran)

Indication: Zofran is a 5-HT3 receptor antagonist indicated for the prevention of nausea and vomiting.

Insight:

  • Dosing: Take 1 tablet every day or as needed prescribed by the provider.
  • Dosage forms: Tablets 4 mg and 8 mg (orally disintegrating tablets available), oral solution 4 mg/5 mL.
  • Adverse events (AEs): The most common AEs in adults are headache, malaise/fatigue, constipation, and diarrhea.
  • Mechanism of action: Ondansetron is a selective 5-HT3 receptor antagonist.
  • Manufacturer: GSK

Sources:

ZOFRAN (ondansetron hydrochloride) Label (fda.gov)

zofran image - Google Search

Related Videos
Senior Doctor is examining An Asian patient.
Healthcare, pharmacist and woman at counter with medicine or prescription drugs sales at drug store.
Image Credit: © Birdland - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
Pharmacy, Advocacy, Opioid Awareness Month | Image Credit: pikselstock - stock.adobe.com
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought